Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.34 -0.02 (-1.47%)
As of: Aug 20, 2026 · 3:59 PM EDT

Sonoma Pharmaceuticals (SNOA) Amortizatization of Intangibles (2010 - 2011)

Sonoma Pharmaceuticals (SNOA) posted quarterly Amortizatization of Intangibles of $156000.0 for Q4 2011, down 37.6% year-over-year from $250000.0 in Q4 2010, and little changed quarter-over-quarter from $156000.0 in Q3 2011.

Sonoma Pharmaceuticals (SNOA) Amortizatization of Intangibles (2010 - 2011) Analysis & Trends

Sonoma Pharmaceuticals' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $156000.0 for Q4 2011.

  • In Q4 2011, Amortizatization of Intangibles fell 37.6% year-over-year to $156000.0; the TTM figure through Mar 2012 stood at $1.2 million (up 66.67% YoY), while the FY2012 annual figure was $1.2 million, up 66.67% from the prior year.
  • Amortizatization of Intangibles for Q4 2011 stood at $156000.0, roughly flat from $156000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $938000.0 in Q2 2011, with the low at $156000.0 in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 900,000.00
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Sonoma Pharmaceuticals 5.17 Mn -165,129.89 2.58 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 156,000.00
Dec 31, 2011 156,000.00
Sep 30, 2011 156,000.00
Sep 30, 2011 156,000.00
Jun 30, 2011 938,000.00
Jun 30, 2011 938,000.00
Dec 31, 2010 250,000.00
Dec 31, 2010 250,000.00
Jun 30, 2010 500,000.00
Jun 30, 2010 500,000.00